Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release 2023 fourth quarter and full year financial and operational results on Thursday, February 15, 2024, before markets open. Aurinia's management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide a general business update. Interested participants can dial 877-407-9170 / +1 201-493-6756 (Toll-free U.S. & Canada). The audio webcast can also be accessed under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia's website.
About Aurinia
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations with high unmet medical needs that are impacted by autoimmune, kidney, and rare diseases. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company's head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.
Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil. ...
Capital Ophthalmic, a leader in the ophthalmic industry with over four decades of expertise, is proud to announce the launch of their comprehensive Preventative Maintenance Programs. These new offerings underscore Capital Ophthalmic's commitment to...
Product: Meat and vegetable products
Issue: Food - Microbial Contamination - Listeria
Distribution:AlbertaBritish ColumbiaPossibly other provinces and territories
See the affected products and product photos for this recall
SOURCE Canadian Food...
On April 27 and 28 at San Francisco's Brava Theatre, Chacruna Institute for Psychedelic Plant Medicines will host its unmissable spring conference: Psychedelic Culture. This year's theme is Cultivating Roots for Cultural Change. Registration is still...
Product: Gift Chocolate
Issue: Food - Allergen - Milk; Food - Allergen - Soy
Distribution: Ontario, Quebec
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)